AstraZeneca stock jumps as COPD drug trial win surprises market
Shares of AstraZeneca rose on Friday after the drugmaker reported positive results from late-stage clinical trials of its experimental chronic obstructive pulmonary disease (COPD) treatment, tozorakimab. The UK-based pharmaceutical company said the drug candidate met its primary objective in two Phase 3 studies, OBERON and TITANIA, marking a significant milestone in its respiratory pipeline. The
